Moreover, it is necessary to consider a new class of drugs for T2DM, such as glucagon-like peptide 1 agonists that seem to have multiple actions in the central nervous system, including antidepressants that can affect the control of diabetes and depression. This evidence concerns the gene GCG and diabetes mellitus.